Bayer, Precision BioSciences in Crop Genome Modification Alliance | GenomeWeb

NEW YORK (GenomeWeb News) – Bayer CropScience, the agricultural subsidiary of Bayer, and Precision BioSciences announced today that they will collaborate on creating site-specific genome modifications in plants.

Under the deal, Bayer will have non-exclusive access to Precision Bio's Direct Nuclease Editor technology, which can be used to develop novel traits in plants, the firms said. Precision Bio also will supply Bayer with multiple DNE-engineered enzymes for use across the company's crop platforms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.